Unknown

Dataset Information

0

Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease.


ABSTRACT: One of the major pathological hallmarks of Alzheimer´s disease (AD) is an accumulation of amyloid-? (A?) in brain tissue leading to formation of toxic oligomers and senile plaques. Under physiological conditions, a tightly balanced equilibrium between A?-production and -degradation is necessary to prevent pathological A?-accumulation. Here, we investigate the molecular mechanism how insulin-degrading enzyme (IDE), one of the major A?-degrading enzymes, is regulated and how amyloid precursor protein (APP) processing and A?-degradation is linked in a regulatory cycle to achieve this balance. In absence of A?-production caused by APP or Presenilin deficiency, IDE-mediated A?-degradation was decreased, accompanied by a decreased IDE activity, protein level, and expression. Similar results were obtained in cells only expressing a truncated APP, lacking the APP intracellular domain (AICD) suggesting that AICD promotes IDE expression. In return, APP overexpression mediated an increased IDE expression, comparable results were obtained with cells overexpressing C50, a truncated APP representing AICD. Beside these genetic approaches, also AICD peptide incubation and pharmacological inhibition of the ?-secretase preventing AICD production regulated IDE expression and promoter activity. By utilizing CRISPR/Cas9 APP and Presenilin knockout SH-SY5Y cells results were confirmed in a second cell line in addition to mouse embryonic fibroblasts. In vivo, IDE expression was decreased in mouse brains devoid of APP or AICD, which was in line with a significant correlation of APP expression level and IDE expression in human postmortem AD brains. Our results show a tight link between A?-production and A?-degradation forming a regulatory cycle in which AICD promotes A?-degradation via IDE and IDE itself limits its own production by degrading AICD.

SUBMITTER: Lauer AA 

PROVIDER: S-EPMC7681056 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease.

Lauer Anna A AA   Mett Janine J   Janitschke Daniel D   Thiel Andrea A   Stahlmann Christoph P CP   Bachmann Cornel M CM   Ritzmann Felix F   Schrul Bianca B   Müller Ulrike C UC   Stein Reuven R   Riemenschneider Matthias M   Grimm Heike S HS   Hartmann Tobias T   Grimm Marcus O W MOW  

Aging cell 20201031 11


One of the major pathological hallmarks of Alzheimer´s disease (AD) is an accumulation of amyloid-β (Aβ) in brain tissue leading to formation of toxic oligomers and senile plaques. Under physiological conditions, a tightly balanced equilibrium between Aβ-production and -degradation is necessary to prevent pathological Aβ-accumulation. Here, we investigate the molecular mechanism how insulin-degrading enzyme (IDE), one of the major Aβ-degrading enzymes, is regulated and how amyloid precursor prot  ...[more]

Similar Datasets

| S-EPMC153065 | biostudies-literature
| S-EPMC8169600 | biostudies-literature
| S-EPMC2756532 | biostudies-literature
| S-EPMC7074877 | biostudies-literature
| S-EPMC6188057 | biostudies-literature
| S-EPMC2597950 | biostudies-literature
| S-EPMC2634517 | biostudies-literature
| S-EPMC3623905 | biostudies-literature
| S-EPMC6730264 | biostudies-literature
| S-EPMC7830943 | biostudies-literature